Through a large-scale MR analysis of female reproductive endocrine diseases using data from a Finnish database, we investigated the effects of three common drug targets (HMGCR, PCSK9, and NPC1L1) on various conditions including PCOS, POF, PMS, menorrhagia, oligomenorrhea, and infertility. Here, PCSK9 is linked to polycystic ovary syndrome.